Access Bio Inc (950130) — Free Cash Flow Generation Index

Latest as of March 2025: 1292.47x

Access Bio Inc (950130) has a Free Cash Flow Generation Index of 1292.47x as of March 2025. Free cash flow of ₩6.92 Billion represents 1292% of operating cash flow (₩5.35 Million). Read 950130 current and long-term liabilities for a breakdown of total debt and financial obligations.

FCF Generation Index

1292.47x
Free Cash Flow / Operating CF

Free Cash Flow

₩6.92 Billion
KRW

Operating Cash Flow

₩5.35 Million
KRW

Capital Expenditures

₩635.11K
KRW

Access Bio Inc Free Cash Flow Generation Index (2012–2024)

Historical FCF Generation Index trend for Access Bio Inc across 8 annual periods. Explore Access Bio Inc capital reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.

Annual Free Cash Flow Generation for Access Bio Inc (2012–2024)

Year-by-year Free Cash Flow Generation Index for Access Bio Inc. For the full company profile including market capitalisation, see 950130 market cap.

Year FCG Index Free Cash Flow (KRW) Operating CF Capital Expenditures YoY Change
2024 1318.33x ₩17.85 Billion ₩13.54 Million ₩1.40 Million ▲ +9.6%
2022 1202.40x ₩350.29 Billion ₩291.33 Million ₩14.90 Million ▲ +28.2%
2021 938.15x ₩129.37 Billion ₩137.90 Million ₩28.76 Million ▲ +132172.7%
2020 0.71x ₩26.05 Billion ₩36.72 Billion ₩10.38 Billion ▼ -87.7%
2016 5.74x ₩12.14 Million ₩2.11 Million ₩10.03 Million ▲ +113.3%
2015 2.69x ₩7.72 Billion ₩2.87 Billion ₩4.85 Billion ▲ +1.3%
2013 2.66x ₩4.22 Billion ₩1.59 Billion ₩2.63 Billion ▲ +55.7%
2012 1.71x ₩3.15 Billion ₩1.85 Billion ₩1.31 Billion
FCG Index = Free Cash Flow / Operating Cash Flow. FCF = Operating CF + Capital Expenditures (capex stored negative).